Literature DB >> 6469750

Cell killing, radiosensitization and cell cycle redistribution induced by chronic hypoxia.

I J Spiro, G C Rice, R E Durand, R Stickler, C C Ling.   

Abstract

Some of the biological changes associated with extreme hypoxia at 37 degrees C (less than 10 ppm pO2) were examined in Chinese hamster V79 cells. Specifically, extreme hypoxia caused an initial decrease in plating efficiency to 55% in 4 hr after the onset of hypoxia. Beyond this time, the decline in plating efficiency was more gradual reaching 35% of control at 20 hr. Flow microfluorimetry (FMF) studies, in which cells are sorted on the basis of DNA content and then assayed for viability, demonstrated that mid S phase cells were most sensitive to chronic hypoxia, with surviving fraction equal to 2.5% at 20 hr. Furthermore, the viability of G1 and G2/M cells, after 20 hr of hypoxic storage, was also reduced to 20 and 7.6%, respectively. Hypoxia also caused alterations in the cell cycle distribution of initially asynchronous cells, as determined by dual parameter FMF measurements of both cellular DNA content and incorporated BudR. In particular, G2/M cells completed mitosis, while G1 cells showed little or no movement. Lastly, cells stored in chronic hypoxia displayed an enhanced radiosensitivity when compared to acutely hypoxic cells. Possible reasons for these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469750     DOI: 10.1016/0360-3016(84)90332-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Authors:  Heidi Högel; Krista Rantanen; Terhi Jokilehto; Reidar Grenman; Panu M Jaakkola
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

2.  Response to multiple radiation doses of fibroblasts over-expressing dominant negative Ku70.

Authors:  Muneyasu Urano; Yunhong Huang; Fuqiu He; Akiko Minami; C Clifton Ling; Gloria C Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells.

Authors:  S D Young; R S Marshall; R P Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

Authors:  T G Graeber; J F Peterson; M Tsai; K Monica; A J Fornace; A J Giaccia
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

6.  Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.

Authors:  L Webster; R J Hodgkiss; G D Wilson
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein.

Authors:  O Amellem; J A Sandvik; T Stokke; E O Pettersen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells.

Authors:  T Danielsen; M Hvidsten; T Stokke; K Solberg; E K Rofstad
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

9.  Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability.

Authors:  N M Hasan; G E Adams; M C Joiner; J F Marshall; I R Hart
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

10.  Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides.

Authors:  O Amellem; M Löffler; E O Pettersen
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.